Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4 Registration of securities (foreign)
- 3.1.1 EX-3.1.1
- 3.1.2 EX-3.1.2
- 3.2.1 EX-3.2.1
- 3.2.2 EX-3.2.2
- 3.3.1 EX-3.3.1
- 3.3.2 EX-3.3.2
- 3.3.3 EX-3.3.3
- 3.4.1 EX-3.4.1
- 3.4.2 EX-3.4.2
- 3.5.1 EX-3.5.1
- 3.5.2 EX-3.5.2
- 3.5.3 EX-3.5.3
- 3.5.4 EX-3.5.4
- 3.6.1 EX-3.6.1
- 3.6.2 EX-3.6.2
- 3.6.3 EX-3.6.3
- 3.7.1 EX-3.7.1
- 3.7.2 EX-3.7.2
- 3.8.1 EX-3.8.1
- 3.8.2 EX-3.8.2
- 3.9.1 EX-3.9.1
- 3.9.2 EX-3.9.2
- 3.10.1 EX-3.10.1
- 3.10.2 EX-3.10.2
- 3.11.1 EX-3.11.1
- 3.11.2 EX-3.11.2
- 3.12 EX-3.12
- 4.1 EX-4.1
- 4.3 EX-4.3
- 4.4 EX-4.4
- 4.5 EX-4.5
- 4.6 EX-4.6
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 5.4 EX-5.4
- 5.5 EX-5.5
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 12.1 EX-12.1
- 21.1 EX-21.1
- 23.6 EX-23.6
- 23.7 EX-23.7
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
Grifols Biologicals similar filings
Filing view
External links
Exhibit 23.7
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form F-4 of Grifols, S.A. of our report dated February 23, 2011, relating to the financial statements and financial statement schedule of Talecris Biotherapeutics Holding Corp., which appear in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
October 24, 2011
October 24, 2011